Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma
Crossref DOI link: https://doi.org/10.1007/s10637-014-0200-8
Published Online: 2015-02-10
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yau, Thomas
Cheng, Paul N.
Chan, Pierre
Chen, Li
Yuen, Jimmy
Pang, Roberta
Fan, Sheung Tat
Wheatley, Denys N.
Poon, Ronnie T.
Text and Data Mining valid from 2015-02-10
Version of Record valid from 2015-02-10
Article History
Received: 6 November 2014
Accepted: 9 December 2014
First Online: 10 February 2015